Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2007
07/19/2007WO2007054453A3 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
07/19/2007WO2007035722A3 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
07/19/2007WO2007023393A3 Novel processes for the production of amorphous rabeprazole sodium
07/19/2007WO2007017828A3 Oxazolidinone-quinolone hybrids as antibacterial compounds
07/19/2007US20070167655 Method for the production of tetrahydrogeranylacetone
07/19/2007US20070167631 Novel herbicides
07/19/2007US20070167621 Substituted pyrimidinones
07/19/2007US20070167507 4-Carbox pyrazole derivatives useful as anti-viral agents
07/19/2007US20070167505 Substituted benzimidazoles and their use for inducing apoptosis
07/19/2007US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof
07/19/2007US20070167491 N-[2-(5-chloro-2-pyridinyl)propyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, used for the control of phytopathogenic fungi of plants; pesticides
07/19/2007US20070167486 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring
07/19/2007US20070167483 Phenylalanine Enamide Derivatives
07/19/2007US20070167481 Imidazonaphthyridines
07/19/2007US20070167471 Substituted quinazoline compounds useful as p38 kinase inhibitors
07/19/2007US20070167470 Spiro compounds and methods of use
07/19/2007US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof
07/19/2007US20070167458 Tetrahydro-naphthalene and urea derivatives
07/19/2007US20070167456 Mercaptoimidazoles as ccr2 receptor antagonists
07/19/2007US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES
07/19/2007US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments
07/19/2007US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
07/19/2007US20070167444 Benzamide derivative or salt thereof
07/19/2007US20070167442 Such as 1-(1-{3-[4-(ethylsulfonyl)piperazin-1-yl]-3-phenylpropyl}piperidin-4-yl)-5-(methylsulfonyl)-1H-benzimidazole; reductive amination
07/19/2007US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors
07/19/2007US20070167440 Novel pyrrolidine compound and a process for preparing the same
07/19/2007US20070167423 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
07/19/2007US20070167421 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
07/19/2007US20070167406 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
07/19/2007US20070166759 Chemiluminescent compounds
07/19/2007DE102006001574A1 Acylaminoimidazole Acylaminoimidazole
07/19/2007CA2635997A1 Morpholino pyrimidine derivatives and their use in therapy
07/19/2007CA2635916A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
07/19/2007CA2635827A1 Anthranilamide derivatives and their use for the control of insects and acari
07/19/2007CA2634138A1 Enantioselective preparation of benzimidazole derivatives and their salts
07/19/2007CA2633722A1 Substituted propiolic acid amides and their use for producing drugs
07/19/2007CA2631360A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments
07/18/2007EP1808432A1 Amorphous object of cinnamide compound
07/18/2007EP1807417A2 Pyrazolylmethyl heteroaryl derivatives
07/18/2007EP1807416A1 Nicotinamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors
07/18/2007EP1807415A2 Novel anthranilamide pyridinureas as vegf receptor kinase inhibitors
07/18/2007EP1807414A1 Insecticidal n,n-di(heteroarylalkyl) amine derivatives
07/18/2007EP1807413A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors
07/18/2007EP1807412A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors
07/18/2007EP1807407A1 Aromatic amides as inhibitors of c-fms kinase
07/18/2007EP1807405A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
07/18/2007EP1807404A1 Novel use
07/18/2007EP1807398A1 New indole or benzimidazole derivatives
07/18/2007EP1807392A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor
07/18/2007EP1807078A1 Diaminoalkane aspartic protease inhibitors
07/18/2007EP1807077A2 Inhibitors of c-fms kinase
07/18/2007EP1807074A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
07/18/2007EP1807072A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/18/2007EP1725239B1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
07/18/2007EP1603912B1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
07/18/2007EP1565436A4 3-aminopyrrolidine derivatives as modulators of chemokine receptors
07/18/2007EP1558598B1 Triazole compounds for the treatment of dysmenorrhoea
07/18/2007EP1515945A4 Method for making aryl hydrazines and substituted indoles
07/18/2007EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
07/18/2007EP1403251B1 Bis(2-aryl-5-pyridyl) derivative
07/18/2007EP1403250B1 Bis(5-aryl-2-pyridyl) derivative
07/18/2007EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
07/18/2007EP1007044B1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
07/18/2007CN1326853C Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
07/18/2007CN1326850C Tricyclic farnesyl protein transferase inhibitors
07/18/2007CN1326849C Hexahydro-phthalmide compound, its preparation and use thereof
07/18/2007CN1326848C Aminopyrazole derivatives
07/18/2007CN1326847C Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases
07/18/2007CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity
07/18/2007CN1326839C 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use
07/18/2007CN1326838C Benzo[d]azepine derivatives for the treatment of neurological disorders
07/18/2007CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
07/18/2007CN1326524C Stable liquid preparation
07/18/2007CN101001852A Pyrazole derivative
07/18/2007CN101001851A Hydroxyamide compounds having activity as inhibitors of histone deacetylase (HDAC)
07/18/2007CN101001850A Amido compounds and their use as pharmaceuticals
07/18/2007CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/18/2007CN101001845A Substituted quinazolones as anti-cancer agents.
07/18/2007CN101001844A Mercaptoimidazoles as CCR2 receptor antagonists
07/18/2007CN101001840A Therapeutic compounds: pyridine as scaffold
07/18/2007CN101001626A Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor
07/18/2007CN100999517A Pyrazole formylamine derivate, its pharmaceutical composition and preparation process
07/18/2007CN100999501A Process for the preparation of 2-methyl piperazine derivatives
07/17/2007US7244847 Bactericides
07/17/2007US7244747 For therapy of epilepsy, epileptogenesis, seizure disorders, convulsions, dyskinesia and neuropathic pain in a mammal
07/17/2007US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors
07/17/2007US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/17/2007US7244744 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels
07/17/2007US7244743 Non-peptidic BRS-3 agonists
07/17/2007US7244738 Urogenital disorders; sexual diosrders; benign prostatic hyperplasia; analgesics
07/17/2007US7244737 Process for the preparation of azoxystrobin and analogues thereof
07/17/2007US7244735 useful for treating cancer, neurological disorders, autoimmune disorders, and other diseases that are alleviated by protein kinase inhibitors
07/17/2007US7244734 For example, (3R,9aR)-(3,5-bis(trifluoromethyl)phenyl)-[3-(1H-indol-3-ylmethyl)-7-pyridin-3-yl-1,3,4,8,9,9a-hexahydro-pyrido[1,2-a]pyrazin-2-yl]-methanone; useful in the treatment of disorders in which neurokinins which interact with NK1 receptors, e.g. neurokinin-1 (=Substance P) are involved
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007US7244726 Heterocyclic compounds possessing affinity at 5HT1 -type receptors and use thereof in therapy
07/17/2007CA2303389C Antimicrobial quinolones, their compositions and uses
07/17/2007CA2258650C Trisubstituted pyridine compounds for herbicidal use
07/12/2007WO2007079239A2 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
07/12/2007WO2007079162A1 Isoxazolines for controlling invertebrate pests
07/12/2007WO2007078251A1 Compounds